Articles published by Bristol Myers Squibb
![](https://mms.businesswire.com/media/20240222161139/en/839392/22/BMY_Logo.jpg)
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer
February 23, 2024
From Bristol Myers Squibb
Via Business Wire
![](https://mms.businesswire.com/media/20240219104533/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20240214420778/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb Prices $13 Billion of Senior Unsecured Notes
February 14, 2024
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20240214620395/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb Recommends Stockholders Reject “Mini-Tender” Offer by Tutanota LLC
February 14, 2024
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20240213315041/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20240211117969/en/2030381/22/Rayze_Logo.jpg)
From Bristol Myers Squibb
Via Business Wire
![](https://mms.businesswire.com/media/20240206288537/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20240205190223/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb Named One of America’s Most JUST Companies by JUST Capital and CNBC
February 05, 2024
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20240202553533/en/1763583/22/BMS_2Seventybio.jpg)
![](https://mms.businesswire.com/media/20240202503029/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
February 02, 2024
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20240129726220/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20240126251451/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20240125476333/en/785876/5/BMS_LOGO.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240122188361/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20240122053621/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20240119767422/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20240116916667/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20231222483443/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20231225781528/en/1979985/22/Rayze_Logo.jpg)
![](https://mms.businesswire.com/media/20231222441927/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb to Present at J.P. Morgan’s 42nd Annual Healthcare Conference
December 22, 2023
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20231220440919/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb to Participate in the 2024 Goldman Sachs Healthcare C-Suite Unscripted Conference
December 20, 2023
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20231215733992/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20231215156427/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb to Report Results for Fourth Quarter 2023 on February 2, 2024
December 15, 2023
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20231210559794/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20231210908115/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20231210772382/en/1763583/22/BMS_2Seventybio.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20231209281713/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20231208530578/en/785876/5/BMS_LOGO.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.